Read More 1 minute read Analyst Ratings News Price Target Wells Fargo Maintains Overweight on Chesapeake Energy, Raises Price Target to $130 By Benzinga Newsdesk July 11, 7:38 AM Wells Fargo analyst Nitin Kumar maintains Chesapeake Energy (NASDAQ:CHK) with a Overweight and raises the price target from $102 to $130. CHK
Read More 1 minute read Analyst Ratings News Price Target Baird Maintains Neutral on Twitter, Lowers Price Target to $33 By Benzinga Newsdesk July 11, 7:36 AM Baird analyst Colin Sebastian maintains Twitter (NYSE:TWTR) with a Neutral and lowers the price target from $45 to $33. TWTR
Read More 1 minute read Analyst Ratings Downgrades News Price Target Wells Fargo Downgrades Civitas Resources to Equal-Weight, Lowers Price Target to $67 By Benzinga Newsdesk July 11, 7:29 AM Wells Fargo analyst Joseph McKay downgrades Civitas Resources (NYSE:CIVI) from Overweight to Equal-Weight and lowers the price target from $69 to $67. CIVI
Read More 1 minute read Analyst Ratings Downgrades News Price Target Wells Fargo Downgrades Centennial Resource Dev to Underweight, Lowers Price Target to $11 By Benzinga Newsdesk July 11, 7:26 AM Wells Fargo analyst Joseph McKay downgrades Centennial Resource Dev (NASDAQ:CDEV) from Equal-Weight to Underweight and lowers the price target from $12 to $11. CDEV
Read More 1 minute read Analyst Ratings Downgrades News Price Target B of A Securities Downgrades Stryker to Neutral, Announces $215 Price Target By Benzinga Newsdesk July 11, 7:20 AM B of A Securities analyst Travis Steed downgrades Stryker (NYSE:SYK) from Buy to Neutral and announces $215 price target. SYK
Read More 1 minute read Analyst Ratings Downgrades News B of A Securities Downgrades ITT to Neutral By Benzinga Newsdesk July 11, 7:16 AM B of A Securities analyst Andrew Obin downgrades ITT (NYSE:ITT) from Buy to Neutral. ITT
Read More 1 minute read Analyst Ratings News Price Target Raymond James Maintains Outperform on HCA Healthcare, Lowers Price Target to $220 By Benzinga Newsdesk July 11, 7:14 AM Raymond James analyst John Ransom maintains HCA Healthcare (NYSE:HCA) with a Outperform and lowers the price target from $245 to $220. HCA
Read More 1 minute read Analyst Ratings Initiation News Price Target EF Hutton Initiates Coverage On Hudson Technologies with Buy Rating, Announces Price Target of $11 By Benzinga Newsdesk July 11, 7:10 AM EF Hutton analyst Chip Moore initiates coverage on Hudson Technologies (NASDAQ:HDSN) with a Buy rating and announces Price Target of $11. HDSN
Read More 1 minute read Analyst Ratings Downgrades News Price Target Citigroup Downgrades Pulmonx to Neutral, Lowers Price Target to $19 By Benzinga Newsdesk July 11, 7:08 AM Citigroup analyst Joanne Wuensch downgrades Pulmonx (NASDAQ:LUNG) from Buy to Neutral and lowers the price target from $23 to $19. LUNG
Read More 1 minute read Analyst Ratings Downgrades News Price Target UBS Downgrades T. Rowe Price Gr to Sell, Lowers Price Target to $88 By Benzinga Newsdesk July 11, 7:04 AM UBS analyst Brennan Hawken downgrades T. Rowe Price Gr (NASDAQ:TROW) from Neutral to Sell and lowers the price target from $138 to $88. TROW